Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

MHC antigens in human melanomas.

D J Ruiter1, V Mattijssen, E B Broecker

  • 1Department of Pathology, University Hospital Nijmegen, The Netherlands.

Seminars in Cancer Biology
|February 1, 1991
PubMed
Summary

Human Leukocyte Antigen (HLA) class I and II antigen distribution in melanocytic lesions impacts prognosis. Loss of HLA class I and expression of HLA class II in melanoma indicate complex regulation and prognostic relevance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Radiological imaging of teratological fetuses: what can we learn?

Insights into imaging·2017
Same author

Stem cells, melanoma and cancer stem cells: the good, the bad and the evil?

Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia·2008
Same author

Repigmentation of skin and hairs in stable vitiligo by transplantation of autologous melanocytes in fibrin suspension.

Journal of the European Academy of Dermatology and Venereology : JEADV·2008
Same author

Expert review remains important in the histopathological diagnosis of cutaneous melanocytic lesions.

Histopathology·2008
Same author

In situ detection of antigen-specific T cells in cryo-sections using MHC class I tetramers after dendritic cell vaccination of melanoma patients.

Cancer immunology, immunotherapy : CII·2007
Same author

Micronodular transformation as a novel mechanism of VEGF-A-induced metastasis.

Oncogene·2007

Area of Science:

  • Immunogenetics
  • Dermatopathology
  • Oncology

Background:

  • Major Histocompatibility Complex (MHC) antigens, specifically Human Leukocyte Antigen (HLA) class I and II, play crucial roles in immune surveillance.
  • Their expression patterns in melanocytic lesions, including melanoma, are critical for understanding immune evasion and tumor progression.
  • Alterations in HLA antigen expression are increasingly recognized as significant in various cancers.

Purpose of the Study:

  • To review the distribution of HLA class I and HLA class II antigens in human melanocytic lesions.
  • To investigate the prognostic relevance of HLA antigen expression in primary melanoma and locoregional metastases.
  • To elucidate the complex regulation of HLA antigens during melanoma development and progression.

Main Methods:

  • Review of existing literature on MHC/HLA antigen distribution in melanocytic lesions.
  • Immunohistochemical analysis of HLA class I (e.g., HLA-A,B,C) and HLA class II (e.g., HLA-DR) antigen expression.
  • Correlation of HLA antigen expression patterns with clinical data, including tumor progression and patient prognosis.

Main Results:

  • HLA class I antigens are broadly distributed but can be downregulated during melanoma progression.
  • HLA class II antigen expression emerges with neoplastic transformation in melanocytic lesions.
  • Expression of HLA-DR in primary melanomas is linked to an unfavorable prognosis.
  • Decreased expression of HLA-A,B,C antigens in locoregional metastases also indicates a poor prognosis.

Conclusions:

  • The expression patterns of HLA class I and II antigens in melanoma are complex and hold significant prognostic value.
  • Immunohistochemical assessment of HLA antigen status can aid in predicting patient outcomes for melanoma.
  • Targeting HLA antigen regulation may represent a future therapeutic strategy in melanoma treatment.

Related Experiment Videos